COLLABRX INC | 2,54 Euro | -0,041 -1,59 % | |
| WKN: A1J5F5 ISIN: US19422J1088 Ticker-Symbol: TG2 | Frankfurt | 24.05.13 | 15:37 Uhr |
Branche NanotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 09.04. | CollabRx inks 2nd overseas deal in a week | 1 | bizjournals | |
| 09.04. | CollabRx (CLRX) Enters Molecular Diagnostics Partnership with Sengenics | 1 | StreetInsider.com | |
| 04.04. | CollabRx and OncoDNA Announce Multi-Year Agreement | - | Benzinga.com | |
| 13.11. | CollabRx to Present at NIBA Conference in Las Vegas November 14-16, 2012 | 17 | Marketwired | |
| SAN FRANCISCO, CA -- (Marketwire) -- 11/13/12 -- CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on genomics, today announced that it is scheduled to present at the National Investment... Mehr lesen zu: CollabRx to Present at NIBA Conference in Las Vegas November 14-16, 2012 | ||||
| 03.10. | CollabRx Partners with Life Technologies in Molecular Diagnostics | 87 | Business Wire | |
| Life Technologies' Cancer Panels to be paired with CollabRx's
Interpretive Analytics
CollabRx, Inc. (NASDAQ: CLRX) today announced a multi-year partnership... Mehr lesen zu: CollabRx Partners with Life Technologies in Molecular Diagnostics | ||||
| 01.10. | XFRA CAPITAL ADJUSTMENT INFORMATION - 01.10.2012 - 2 | 295 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 01.10.2012 EX KAPITALMASSNAHME GEHANDELT.
THE FOLLOWING SHARES ARE TRADED EX CAPITAL ADJUSTMENT ON 01.10.2012.
INSTR EXCH ISIN INSTRUMENT NAME
XFRA US8790083088 TEGAL... Mehr lesen zu: XFRA CAPITAL ADJUSTMENT INFORMATION - 01.10.2012 - 2 | ||||
| 28.09. | XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 28.09.2012 | 618 | Xetra Newsboard | |
| The following instruments on XETRA do have their last trading day on
28.09.2012
Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am
28.09.2012
ISIN Name
CA3865651051 GRANDEZA... Mehr lesen zu: XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 28.09.2012 | ||||
| 28.09. | XFRA TG2, 1ZA, S1KA, T7I!: AENDERUNG / CHANGE ISIN | 107 | Xetra Newsboard | |
| FUER FOLGENDE INSTRUMENTE WERDEN ISIN. WKN UND KUERZEL GEAENDERT. GUELTIG
AB 01.10.2012
FOR THE FOLLOWING INSTRUMENTS ISIN, WKN AND SHORT CODE WILL CHANGE. VALID
FROM OCTOBER 01, 2012
EINSTELLUNG... Mehr lesen zu: XFRA TG2, 1ZA, S1KA, T7I!: AENDERUNG / CHANGE ISIN | ||||
| 27.09. | XFRA TG2: AUSSETZUNG/SUSPENSION | 13 | Xetra Newsboard | |
| DIE FOLGENDE AKTIE IST AB SOFORT AUSGESETZT:
THE FOLLOWING SHARE IS SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
Tegal Corp. TG2 US8790083088 BAW/UFN Mehr lesen zu: XFRA TG2: AUSSETZUNG/SUSPENSION | ||||
| 14.06. | Tegal Corporation Reports Fiscal Year 2012 Financial Results | 37 | Business Wire | |
| Tegal Corporation (NASDAQ:TGAL) today announced financial results for
the Fourth Quarter and Fiscal Year 2012, which ended March 31, 2012.
Fiscal 2012 Fourth... Mehr lesen zu: Tegal Corporation Reports Fiscal Year 2012 Financial Results | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| WESTAIM | 0,569 | 0 % | Westaim Announces Commencement of Trading of Its Common Shares on the TSX Venture Exchange |
| ALTAIR NANOTECHNOLOGIES | 1,872 | -0,16 % | Altair Nanotechnologies Reports First Quarter 2013 Financial Results |
| AMCOL INTERNATIONAL | 24,241 | -0,38 % | AMCOL International (NYSE: ACO) Holds Annual Shareholders Meeting and Announces Quarterly Dividend |
| PSIVIDA | 2,191 | +3,01 % | PSivida Corporation And GTx: 2 Of The Most Undervalued Biotechs For 2013 |
| NANOPHASE TECHNOLOGIES | 0,203 | +0,50 % | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-016 |
